Heather Elizabeth Preston's most recent trade in Aligos Therapeutics Inc was a trade of 120,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 7, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Aligos Therapeutics Inc | Heather Elizabeth Preston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
Fusion Pharmaceuticals Inc | Heather Elizabeth Preston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
Fusion Pharmaceuticals Inc | Heather Elizabeth Preston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) |